MicroPort CRM develops solutions for the management of cardiac rhythm disorders and heart failure.
MicroPort® CRM is a pioneering company in the field of Cardiac Rhythm Management (CRM), and a subsidiary of MicroPort® Scientific Corporation (stock code: 00853.HK), with world headquarters in Clamart, just outside Paris, France. Through its long-standing expertise in CRM, MicroPort® CRM develops, manufactures and markets around the world cardiac pacemakers, implantable cardiac defibrillators, cardiac resynchronization systems and ECG diagnostic solutions for the management of cardiac rhythm disorders and heart failure. Its state-of-the-art products are manufactured in Clamart, France, Saluggia, Italy, Santo Domingo, Dominican Republic, and Shanghai, China.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 26, 2021 | Series C | $150M | 2 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 30, 2021
Loopi
|
Seed | $5M | Apps | — |
May 18, 2021
Pebble Health
|
Series Unknown | $5.09M | Health Care | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Wanhai Investment | — | Series C |
Yongrong Asset | — | Series C |